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1. Introduction 
Tryptophan 2,3dioxygenase (tryptophan pyrrolase, 
Ltryptophan: oxygen 2,3-oxidoreductase (d cyclizing), 
EC 1.13.11 .I 1) catalyses the first reaction of trypto- 
phan catabolism through the kynurenine pathway to 
acetyl CoA: 
L-tryptophan + O2 + N-formylkynurenine 
The enzyme is found in many organisms, but in 
mammals i restricted to the liver. As a frequent with 
regulatory enzymes in liver, tryptophan 2,3dioxy- 
genase concentrations change markedly with variations 
in dietary and hormonal status [ 11. Basal activities 
are, however, very low and have presented problems 
in assaying. A number of procedures have been used 
for quantitating the enzyme, but are open to criticism 
on practical grounds. The formation of kynurenine 
(produced by the cleavage of formylkynurenine by an 
active formylase) can be followed spectrophoto- 
metrically in both continuous [2] and stopped [3] 
assays, but the sensitivity is low, and relatively large 
amounts of tissue are required. The presence of ape- 
and holo- forms of the enzyme necessitates a prein- 
cubation period with a haem compound, ascorbate 
and tryptophan before assay [4 1. This preincubation 
increases blank values and the assay is further compli- 
cated by absorbance increases attributable to reaction 
between ascorbate and other components [5]. 
A radiochemical ssay based on D,L-[ring-2-r4C]- 
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tryptophan has been devised [6], but has not been 
widely used, probably because of the difficulty of 
preincubation, the need for ionexchange column 
chromatography and the use of optically unresolved 
labelled substrate. 
In whole tissues and organisms, the activity of 
tryptophan 2,3dioxygenase has been determined 
both by chromatographic determination ofkynurenine 
[7] and by formation of r4C02 from labelled substrate 
[8,9], as well as by removal of tryptophan [IO]. More 
recently, this has been reexamined with purified 
L-[ring-2-r4C ] tryptophan and determination of all 
products [111. Here, we report the development of
this last system to provide an assay procedure, suitable 
for crude extracts, which is sensitive, reproducible 
and easy to perform. 
2. Materials and methods 
2.1. Materials 
Norit GSX was from the Norit Clydesdale Co., 
Glasgow. D,L-[ring-2-r4C]tryptophan was from 
Schwarz-Mann, Orangeburg, NY, or ICN through 
Laboratory Impex, Twickenham, and was resolved 
optically by affinity chromatography on immobilized 
bovine serum albumin [ 11 ,121 (L-[ting-2-14C]- 
tryptophan is available from CEA, Gif-sur-Yvette.) 
Other chemicals, of the purest grade available, were 
from standard suppliers. 
Male SpragueDawley rats (1 SO-250 g), were used 
throughout. In some experiments, enzyme activity 
was increased by injection i.p. of L-tryptophan 
(750 mg/kg body wt, in 0.9% (w/v) NaCI, 0.1% (w/v) 
Tween 80) and triamcinolone (1 mg/kg body wt in 
0.9% (w/v) NaCl) every 4 h for a total of 12 h. 
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2.2. fieparation of ex tracts 
Livers were dispersed, with a mechanical tissue 
disintegrator (Ystral GmbH), in 3 ml 0.14 M KCl, 
0.02 M Na-phosphate (pH 7.0)/g tissue. After centrif- 
ugation at 38 000 X g, 40 min, 4°C the supematants 
were decanted and stored at 0°C for assay. 
2.3. Assay of tryptophan 2,3dioxygenase activity 
For comparative purposes, enzyme activity was 
measured spectrophotometricahy after preincubation 
according to [13]. 
The standard assay procedure was as follows: Liver 
extract was preincubated in a medium containing 
50 mM Na-phosphate, 30 mM Na-ascorbate, 2.5 mM 
L-tryptophan and 0.5 mg methaemoglobin (pH 7 .O) 
in 1 ml total vol. at 37’C for 30 mm. This ensures 
that all apoenzyme is converted to the holo-form. 
Portions of each incubation were then transferred 
to 1.5 mlplastic conical (Eppendorf) centrifuge tubes, 
and an equal volume of a suspension of Norit GSX in 
water (50 mg/ml) was added. After mixing, the 
charcoal was removed by centrifugation at 12 000 X g 
for 2 min. This procedure quantitatively removes all 
tryptophan [11,141. 
Appropriate volumes of supematants containing 
10 pg methaemoglobin were added to medium whose 
final composition was 60 mM Na-phosphate, 30 mM 
Naascorbate, 10 pg methaemoglobin a d 0.5 mM 
L-tryptophan (containing 0.06 &i L-[ring-2-14C]- 
tryptophan) @H 7.0); final vol. 0.1 ml, in 1.5 ml 
‘Eppendorf tubes (without stoppers). The tubes were 
preincubated at 30°C for 5 min before the addition 
of tryptophan, and were then placed in 15 ml conical 
glass centrifuge tubes. These were closed with a 
rubber stopper through which was suspended a 
disposable polypropylene centre well (Kontes, NJ) 
containing asmall piece of folded filter paper. 
Incubations were at 30°C in triplicate, and were 
terminated at 60 min (or other times; section 3) by 
the injection (through the stoppers) of 50 $0.6 M 
HC104 into the reaction mixture. Immediately after- 
wards, 0.2 ml phenylethylamine/methanol (1: 1, v/v) 
was injected similarly into the centre wells. All tubes 
were then gently shaken (75 osc./min) at room 
temperature for 60 min to ensure complete absorption 
of 14C02. Wells were removed and added directly to 
scintillation vials containing 5ml Cocktail T scintilla- 
tion fluid (Hopkin and Williams, Chadwell Heath, 
Essex). 
The ‘Eppendorf’ tubes were removed carefully, 
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and 0.1 mlNorit GSX suspension (50 mg/ml in water) 
was added to each. After thorough mixing, precipi- 
tated protein and charcoal were removed by centrif- 
ugation (12 000 X g, 2 mm, room temperature) and 
0.1 ml portions of the supernatant were mixed with 
1 ml PCS scintillation cocktail (Hopkin and Williams, 
Chadwell Heath, Essex) in minivials. The first scintilla- 
tion vial contains the total counts released as 14C02, 
and the second known fraction of the counts in 
non-aromatic 14C-labelled products (very largely 
formate). Under these conditions the binding of 
[14C]tryptophan is quantitative; [14C]formate is not 
bound to charcoal [141. Blanks with no enzyme 
added therefore give counts little above background. 
The usual blanks performed involve addition of HC104 
at zero time; the total counts so obtained are maxi- 
mally <0.25% of those added as [“Cl tryptophan. 
3. Results and discussion 
The product of the tryptophan 2,3dioxygenase- 
catalysed reaction is N-formylkynurenine. In crude 
extracts, however, the presence of a high activity 
fomrylase nsures that for-mate and kynurenine are 
generated [2,3]. Formate may be metabolised in the 
whole cell either through the tetrahydrofolatedepen- 
dent pathway or by direct oxidation involving catalase 
[ 151. In extracts, the latter pathway still persists o 
that a proportion of the formate generated isoxidised 
to COZ. Methods involving determination of for-mate 
alone [ 61, therefore, will underestimate rue activities. 
These procedures measure both CO* and non-aromatic 
products, so that any conversion of formate to other 
‘simple’ molecules does not affect the validity of the 
assay. This method is furthermore not dependent on 
the presence of formylase, since N-formylkynurenine 
hydrolyses rapidly in acid solution [ 161. 
Enzyme activity, as implied above, is calculated 
from the sum of r4C02 and non-aromatic [‘*Cl- 
products. Appropriate corrections for quenching were 
made after counting reagent blanks to which known 
amounts of label were added. Under standard condi- 
tions, the counts in 14C02 after 60 min incubations 
are -5% of the total counts. Over longer periods, 
however, this percentage increases. Furthermore, the 
proportion found as ‘COs’ increases with the length 
of exposure to HC104 (<lOO% at 24 h); this may be 
attributable to direct absorption of free HCOOH by 
the phenylethylamine. 
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Fig.1. (A) Time COUTS~S oftryptoph~ oxidation with different extract concentrations. The liver extract was from rats previously 
given tryptophatr and triamcinolone; it was 270 mg wet tissue/ml and the tryptophan 2,3dioxygenase activity 6.87 nmol _ mg wet 
tissue-’ . h-‘. AB points are the means of 3 determinations. VoIumes of extract: (0) 1.5 ri (0) 3 ~1; (a) 6 ~1: (=) 12 ~1. Insert: 
Rate with ‘non-induced’ extract. Values are means * SD of 3 determinations. (B) Linearity of response to increasing extract con- 
centration. Conditions were as above: (0) 10 min; (e) 20 mm; (0) 30 min; (u) 60 min; (A) 90 min. Ordinate: (A,B) nmol 
L-tryptophan oxidised; (insert) nmol L-tryptophan oxidised/mg wet wt. 
The reaction is linear with respect o both time 
and extract concentration i  extracts containing both 
basal and induced activities (figA), provided that 
<20 nmol substrate are utilized. Simultaneous 
spe~trophotome~i~ assays of liver extracts how that 
identical results are obtained with this radiometric 
method and conventional systems. 
It was thought heoretically possible that ‘activated’ 
enzyme in extracts might revert o the ape-form after 
removal of the activating factors with charcoal (at the 
end of the preincubation period). It was found, 
however, that samples can be left for at least 60 min 
(and possibly longer) after the addition of charcoal 
without any diminution in the activity with L-[ring 2- 
14C I tryptophan with both basal and induced activities, 
provided that methaemo~obin is present in the final 
assay medium. Similar results were also obtained 
when the enzyme was assayed spectrophotometrically. 
Enzyme activity increased sigmoidally with 
increases in tryptophan concentration (fig.2), in 
agreement with [17]. Calculation of the app. Km 
yields 0.35 mM, in the middle of the range reported 
fl8-211. 
This procedure mploys a concentration of 
tryptophan (0.5 mM) which is below that giving 
maximal rates. Higher concentrations can be used as 
easily, but of course involve more isotope or lower 
specific activities. Measurements at 2.5 mM (i.e., 
maximal velocity) and 0.5 mM tryptophan give a 
ratio of rates of 1.96 _+ 0.08 (mean f SEM, 6 determ.). 
With the specific activity used routinely for this 
work, it is possible to achieve reproducible nzyme 
activities in as little as 2 mg of liver from control, 
‘basal’, rats. This compares with the d~~culty of 
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Fig.2. Effect of tryptophan concentration on enzyme activity 
in a crude extract from the liver of a rat previously given 
tryptophan and triamcinolone. 
obtaining trustworthy values with 20-50 mg tissue 
using spectrophotometric methods. The sensitivity 
can be increased appreciably by raising the specific 
activity of the [14C~t~ptoph~, and the backgrounds 
are suf~cien~y low to make this practicable. As 
described, the cost/assay is-$0.20 (US). 
The only other activity which can interfere with 
this assay system (as with all others) is that of the 
less-specific indoleamine 2,3dioxygenase (EC 
1.13.11.17). No example is recorded, however, of the 
two enzymes occurring in the same source, 
This assay requires readily available chemicals with 
a minimum of purification procedures, issimple, 
sensitive, reproducible and easy to perform with large 
numbers of samples. It may further be simply adapted 
(by omission of the pre-~cubation step) for measure- 
ments of the proportions of both ape- and halo- 
enzyme. 
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